Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00095589 · ClinicalTrials.gov registry record
Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- 125
- Enrollment target
NCT00095589 is a clinical trial that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 125 participants.
The verdict
NCT00095589 has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
RATIONALE: New diagnostic procedures such as microsatellite analysis of sediment in the urine may improve the ability to detect bladder cancer without invasive procedures. PURPOSE: Diagnostic trial to study the effectiveness of microsatellite analysis of sediment in the urine in detecting bladder cancer in healthy participants, participants who have genitourinary conditions requiring cystoscopy, and patients who have bladder cancer.
Interventions
- GENETIC microarray analysis
- OTHER laboratory biomarker analysis
- OTHER cytology specimen collection procedure
- GENETIC microsatellite instability analysis
- GENETIC loss of heterozygosity analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2004-08 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00095589
The ClinicalTrials.gov registry entry for NCT00095589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which microarray analysis is the first listed.
NCT00095589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00095589 about?
NCT00095589 is a clinical study titled "Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer". RATIONALE: New diagnostic procedures such as microsatellite analysis of sediment in the urine may improve the ability to detect bladder cancer without invasive procedures. PURPOSE: Diagnostic trial to study the effectiveness of microsatellite analysis of sediment in the urine in detecting bladder c...
What is the current status of trial NCT00095589?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2004-08. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00095589?
The interventions under investigation include: microarray analysis (GENETIC), laboratory biomarker analysis (OTHER), cytology specimen collection procedure (OTHER), microsatellite instability analysis (GENETIC), loss of heterozygosity analysis (GENETIC).
Who is sponsoring clinical trial NCT00095589?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.